Scientific Reports (Apr 2023)
Author Correction: Increased diversity with reduced “diversity evenness” of tumor infiltrating T-cells for the successful cancer immunotherapy
- Akihiro Hosoi,
- Kazuyoshi Takeda,
- Koji Nagaoka,
- Tamaki Iino,
- Hirokazu Matsushita,
- Satoshi Ueha,
- Shin Aoki,
- Kouji Matsushima,
- Masato Kubo,
- Teppei Morikawa,
- Kazutaka Kitaura,
- Ryuji Suzuki,
- Kazuhiro Kakimi
Affiliations
- Akihiro Hosoi
- Department of Immunotherapeutics, The University of Tokyo Hospital
- Kazuyoshi Takeda
- Division of Cell Biology, Biomedical Research Center, Graduate School of Medicine, Juntendo University
- Koji Nagaoka
- Department of Immunotherapeutics, The University of Tokyo Hospital
- Tamaki Iino
- Department of Immunotherapeutics, The University of Tokyo Hospital
- Hirokazu Matsushita
- Department of Immunotherapeutics, The University of Tokyo Hospital
- Satoshi Ueha
- Department of Molecular Preventive Medicine, Graduate School of Medicine, The University of Tokyo
- Shin Aoki
- Department of Molecular Preventive Medicine, Graduate School of Medicine, The University of Tokyo
- Kouji Matsushima
- Department of Molecular Preventive Medicine, Graduate School of Medicine, The University of Tokyo
- Masato Kubo
- Laboratory for Cytokine Regulation, Research Center for Integrative Medical Science (IMS), RIKEN Yokohama Institute
- Teppei Morikawa
- Department of Pathology, Graduate School of Medicine, The University of Tokyo
- Kazutaka Kitaura
- Repertoire Genesis Inc.
- Ryuji Suzuki
- Repertoire Genesis Inc.
- Kazuhiro Kakimi
- Department of Immunotherapeutics, The University of Tokyo Hospital
- DOI
- https://doi.org/10.1038/s41598-023-33836-2
- Journal volume & issue
-
Vol. 13,
no. 1
pp. 1 – 1
Abstract
No abstracts available.